Promising HCV Combo May Not See Light of Day (CME/CE)

BOSTON (MedPage Today) — In a trial described by one expert as a “home run,” a combination of two investigational oral hepatitis C (HCV) medications delivered highly promising results, but its future is iffy.

Post a Comment

Comments are closed.